Whitehouse Station, N.J.-based Merck (MRK) - Get Report reported a profit on Tuesday of $1.64 billion, or 78 cents per share, beating out analysts predictions of earnings per share of 74 cents and revenue of $5.98 billion. The maker of numerous drugs, including Singulair, Zostavax and Fosamax, credits restricting and lower fourth-quarter costs for materials and production with boosting the bottom line.

This piece of earnings news along with a surprising spike in pending home sales in December gave the market a nice lift on Tuesday, led by such stocks as


(CSCO) - Get Report



(PFE) - Get Report



(MSFT) - Get Report


But will this be enough?

With this in mind, we thought we'd take a look at some of the stocks people have been searching for on


and see what

Jim Cramer's had to say about them lately


To read more,

visit Stockpickr.com


Stockpickr is a wholly owned subsidiary of TheStreet.com.